Search results for " TYPE 2 DIABETES"

showing 6 items of 86 documents

Incretin-Based Therapies, Glucometabolic Health and Endovascular Inflammation

2013

Incretin peptides are a group of gastrointestinal hormones that play a prominent role in the regulation of glucose metabolism. Incretin-based therapies (IBTs) have recently emerged as an important treatment option for patients with type 2 diabetes mellitus (T2DM). These pharmaceutical agents may be specially well suited for patients who are overweight or obese with primarily post-meal glucose peaks, and in whom traditional first-line oral agents have failed to maintain adequate glycemic control. There are 2 classes of IBTs: the dipeptidyl peptidase-4 (DPP-4) inhibitors and the glucagon-like peptide 1 (GLP-1) receptor agonists. The ultimate effect of both types of agents is to augment GLP-1 …

medicine.medical_specialtyLipoproteinsIncretin type 2 diabetes mellitus metabolic syndrome lipoproteinsIncretinBiologyIncretinsGlucagon-Like Peptide-1 ReceptorWeight lossDiabetes mellitusInternal medicineDrug DiscoverymedicineAnimalsHumansGlucose homeostasisAdiponectin secretionLipoproteinInflammationPharmacologyDipeptidyl-Peptidase IV InhibitorsDrug Discovery3003 Pharmaceutical ScienceMedicine (all)digestive oral and skin physiologyGlucagon secretionType 2 Diabetes MellitusIncretinAtherosclerosismedicine.diseaseMetabolic syndromeType 2 diabetes mellituGlucoseEndocrinologyDiabetes Mellitus Type 2Metabolic syndromemedicine.symptomCurrent Pharmaceutical Design
researchProduct

Impact of chronic diuretic treatment on glucose homeostasis

2013

Background The use of diuretics for hypertension has been associated with unfavorable changes in cardiovascular risk factors, such as uric acid and glucose tolerance, though the findings in the literature are contradictory. Methods This study investigated whether diuretic use is associated with markers of metabolic and cardiovascular risk, such as insulin-resistance and uric acid, in a cohort of adults without known diabetes and/or atherosclerotic cardiovascular disease. Nine hundred sixty-nine randomly selected participants answered a questionnaire on clinical history and dietary habits. Laboratory blood measurements were obtained in 507 participants. Results Previously undiagnosed type 2 …

medicine.medical_specialtySettore MED/09 - Medicina InternaEndocrinology Diabetes and Metabolismmedicine.medical_treatmentSettore MED/50 - Scienze Tecniche Mediche ApplicateType 2 diabetesGastroenterologySettore MED/13 - Endocrinologiachemistry.chemical_compoundInsulin resistanceDiabetes mellitusInternal medicineInternal MedicinemedicineGlucose homeostasisSettore MED/49 - Scienze Tecniche Dietetiche ApplicateDiureticsbusiness.industryResearchInsulin resistanceType 2 diabetesmedicine.diseaseDiuretics Hypertension Insulin resistance Type 2 diabetes Uric acidEndocrinologychemistryHypertensionCohortUric acidDiureticbusinessUric acidBody mass index
researchProduct

Gestational diabetes and the metabolic syndrome: Can obesity and small, dense low density lipoproteins be key mediators of this association?

2013

Gestational diabetes mellitus (GDM) represents a condition of glucose intolerance with first appearance or recognition at the time of a pregnancy, associated with an inadequate pancreatic response to the advanced insulin resistance of the later stages of pregnancy, and accompanied by enhancing β-cell mass and secretion of insulin. Women who had GDM exhibit a higher risk for later advent of type 2 diabetes mellitus (T2DM) and cardiovascular diseases (CVD). Additionally, previous GDM has been proposed as independently correlated with higher risk for development of atherosclerosis in a healthy population, similar to the metabolic syndrome (MetS) and independently of the presence of established…

medicine.medical_specialtyendocrine system diseasesPharmaceutical ScienceInsulin resistancePregnancyDiabetes mellitusInternal medicineHumansMedicineObesityMetabolic SyndromePregnancybusiness.industryObstetricsnutritional and metabolic diseasesType 2 Diabetes Mellitusmedicine.diseaseObesityLipoproteins LDLGestational diabetesDiabetes GestationalEndocrinologyFemaleMetabolic syndromecardiovascular disease cardiovascular risk gestational diabetes mellitus metabolic syndrome small dense low-density lipoprotein type 2 diabetes mellitusbusinessPostpartum periodBiotechnology
researchProduct

Heart rate recovery after exercise and maximal oxygen uptake in sedentary patients with type 2 diabetes

2015

Aims: Heart rate recovery after exercise (HRR) is an estimate of autonomic modulation of the heart, and has been shown to be inversely associated with insulin resistance, metabolic syndrome, and type 2 diabetes [1]. Type 2 diabetes is associated with poor exercise tolerance and maximal aerobic capacity (VO2max) [2]. Aim of our study was to assess the relationship between HRR and VO2max in sedentary patients with type 2 diabetes. Methods: Maximal treadmill exercise testing using standard or modified Bruce protocol was performed in 16 (8 males and 8 females) sedentary patients with type 2 diabetes (T2D), and in 16 (9 males and 7 females) age-matched sedentary non-diabetic controls (ND). HRR (…

metabolism fat oxidation rate oxygen uptake exercise diabetes.Settore M-EDF/01 - Metodi E Didattiche Delle Attivita' MotorieHeart rate recovery Maximal oxygen uptake Type 2 diabetes
researchProduct

GLP-2: a potential signal for improving glycemic control

2015

obesity - Type 2 Diabetes - GLP-2
researchProduct

Should we measure routinely oxidized and small dense low-density lipoproteins in subjects with type 2 diabetes

2010

oxidized and small dense low-density lipoproteins type 2 diabetes
researchProduct